![Hubert Birner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hubert Birner
Direktör/Styrelseledamot på
CENTOGENE N.V.
Profil
Dr. Hubert Birner is an Independent Member-Supervisory Board at Centogene NV, a Managing Partner at TVM Capital GmbH, a Chairman at AL-S Pharma AG and a Chairman-Supervisory Board at leon-nanodrugs GmbH.
He is on the Board of Directors at Centogene NV, SpePharm AG and Centogene AG.
Dr. Birner was previously employed as an Independent Director by Acer Therapeutics, Inc., an Independent Director by Horizon Pharma, Inc., a Chairman-Supervisory Board by SpePharm Holding BV, an Independent Director by Proteon Therapeutics, Inc., a Chairman by Argos Therapeutics, Inc., a Chairman-Supervisory Board by DIREVO Biotech AG, a Marketing Director & Head-Business Development by Zeneca Agrochemicals, a Marketing Director by Zeneca AGro Gmbh, an Assistant Professor by Ludwig-Maximilians-Universität München, a Chairman by NOXXON Pharma AG, a Chairman-Supervisory Board by NOXXON Pharma NV, and a Managing Partner by TVM Life Science Management GmbH.
He also served on the board at Opexa Therapeutics, Inc., Vivoryon Therapeutics AG, Horizon Pharma Switzerland GmbH, TransMolecular, Inc., BioXell SpA, Evotec SE, Jerini AG and Euronext Paris SA. He received his MBA from Harvard Business School and a doctorate degree from Ludwig-Maximilians-Universität München.
Aktiva positioner av Hubert Birner
| Företag | Position | Start |
|---|---|---|
| CENTOGENE N.V. | Direktör/Styrelseledamot | 2019-04-01 |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Provides diagnostic laboratory testing services | Direktör/Styrelseledamot | 2019-04-01 |
AL-S Pharma AG
 AL-S Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, translational research and clinical development services | Ordförande | - |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Ordförande | - |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology Acquires, registers, and markets medical value medicines for the hospital sector | Direktör/Styrelseledamot | - |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital invests in companies located in the United States and Europe. The firm focuses on information technology, communications and life sciences sectors. It provides financing for early and later stage capital requirements. It also acts as lead or co-lead investor. | Privat kapitalinvesterare | 2000-10-01 |
Tidigare kända positioner av Hubert Birner
| Företag | Position | Slut |
|---|---|---|
| TME PHARMA N.V. | Ordförande | 2019-06-25 |
| ACER THERAPEUTICS INC. | Direktör/Styrelseledamot | 2019-05-17 |
| VIVORYON THERAPEUTICS N.V. | Direktör/Styrelseledamot | 2015-01-01 |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Hubert Birners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
81
Första gradens relationer
27
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 27 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Health Technology |
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital invests in companies located in the United States and Europe. The firm focuses on information technology, communications and life sciences sectors. It provides financing for early and later stage capital requirements. It also acts as lead or co-lead investor. | Finance |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Zeneca Agrochemicals | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
TransMolecular, Inc.
 TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Health Technology |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Finance |
DIREVO Biotech AG
 DIREVO Biotech AG Miscellaneous Commercial ServicesCommercial Services Researches on screening-based directed evolution of genes and proteins | Commercial Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
SpePharm Holding BV
 SpePharm Holding BV Pharmaceuticals: MajorHealth Technology Acquires, registers, and markets medical value medicines for the hospital sector | Health Technology |
Zeneca AGro Gmbh | |
Horizon Pharma, Inc.
 Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpePharm AG
SpePharm AG Pharmaceuticals: MajorHealth Technology Acquires, registers, and markets medical value medicines for the hospital sector | Health Technology |
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Provides diagnostic laboratory testing services | Health Services |
TVM Life Science Management GmbH
 TVM Life Science Management GmbH Miscellaneous Commercial ServicesCommercial Services Provides management services | Commercial Services |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
AL-S Pharma AG
AL-S Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides drug discovery, translational research and clinical development services | Commercial Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Centogene NV
 Centogene NV Medical SpecialtiesHealth Technology Provides genetic diagnostic analyses of rare inherited diseases | Health Technology |
